Human PIGR ORF/cDNA clone-Lentivirus particle (NM_002644.4)

Cat. No.: vGMLV001469

Pre-made Human PIGR/ Lentiviral expression plasmid for PIGR lentivirus packaging, PIGR lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to PIGR products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV001469 Human PIGR Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV001469
Gene Name PIGR
Accession Number NM_002644.4
Gene ID 5284
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2295 bp
Gene Alias
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCTGCTCTTCGTGCTCACCTGCCTGCTGGCGGTCTTCCCAGCCATCTCCACGAAGAGTCCCATATTTGGTCCCGAGGAGGTGAATAGTGTGGAAGGTAACTCAGTGTCCATCACGTGCTACTACCCACCCACCTCTGTCAACCGGCACACCCGGAAGTACTGGTGCCGGCAGGGAGCTAGAGGTGGCTGCATAACCCTCATCTCCTCGGAGGGCTACGTCTCCAGCAAATATGCAGGCAGGGCTAACCTCACCAACTTCCCGGAGAACGGCACATTTGTGGTGAACATTGCCCAGCTGAGCCAGGATGACTCCGGGCGCTACAAGTGTGGCCTGGGCATCAATAGCCGAGGCCTGTCCTTTGATGTCAGCCTGGAGGTCAGCCAGGGTCCTGGGCTCCTAAATGACACTAAAGTCTACACAGTGGACCTGGGCAGAACGGTGACCATCAACTGCCCTTTCAAGACTGAGAATGCTCAAAAGAGGAAGTCCTTGTACAAGCAGATAGGCCTGTACCCTGTGCTGGTCATCGACTCCAGTGGTTATGTAAATCCCAACTATACAGGAAGAATACGCCTTGATATTCAGGGTACTGGCCAGTTACTGTTCAGCGTTGTCATCAACCAACTCAGGCTCAGCGATGCTGGGCAGTATCTCTGCCAGGCTGGGGATGATTCCAATAGTAATAAGAAGAATGCTGACCTCCAAGTGCTAAAGCCCGAGCCCGAGCTGGTTTATGAAGACCTGAGGGGCTCAGTGACCTTCCACTGTGCCCTGGGCCCTGAGGTGGCAAACGTGGCCAAATTTCTGTGCCGACAGAGCAGTGGGGAAAACTGTGACGTGGTCGTCAACACCCTGGGGAAGAGGGCCCCAGCCTTTGAGGGCAGGATCCTGCTCAACCCCCAGGACAAGGATGGCTCATTCAGTGTGGTGATCACAGGCCTGAGGAAGGAGGATGCAGGGCGCTACCTGTGTGGAGCCCATTCGGATGGTCAGCTGCAGGAAGGCTCGCCTATCCAGGCCTGGCAACTCTTCGTCAATGAGGAGTCCACGATTCCCCGCAGCCCCACTGTGGTGAAGGGGGTGGCAGGAGGCTCTGTGGCCGTGCTCTGCCCCTACAACCGTAAGGAAAGCAAAAGCATCAAGTACTGGTGTCTCTGGGAAGGGGCCCAGAATGGCCGCTGCCCCCTGCTGGTGGACAGCGAGGGGTGGGTTAAGGCCCAGTACGAGGGCCGCCTCTCCCTGCTGGAGGAGCCAGGCAACGGCACCTTCACTGTCATCCTCAACCAGCTCACCAGCCGGGACGCCGGCTTCTACTGGTGTCTGACCAACGGCGATACTCTCTGGAGGACCACCGTGGAGATCAAGATTATCGAAGGAGAACCAAACCTCAAGGTACCAGGGAATGTCACGGCTGTGCTGGGAGAGACTCTCAAGGTCCCCTGTCACTTTCCATGCAAATTCTCCTCGTACGAGAAATACTGGTGCAAGTGGAATAACACGGGCTGCCAGGCCCTGCCCAGCCAAGACGAAGGCCCCAGCAAGGCCTTCGTGAACTGTGACGAGAACAGCCGGCTTGTCTCCCTGACCCTGAACCTGGTGACCAGGGCTGATGAGGGCTGGTACTGGTGTGGAGTGAAGCAGGGCCACTTCTATGGAGAGACTGCAGCCGTCTATGTGGCAGTTGAAGAGAGGAAGGCAGCGGGGTCCCGCGATGTCAGCCTAGCGAAGGCAGACGCTGCTCCTGATGAGAAGGTGCTAGACTCTGGTTTTCGGGAGATTGAGAACAAAGCCATTCAGGATCCCAGGCTTTTTGCAGAGGAAAAGGCGGTGGCAGATACAAGAGATCAAGCCGATGGGAGCAGAGCATCTGTGGATTCCGGCAGCTCTGAGGAACAAGGTGGAAGCTCCAGAGCGCTGGTCTCCACCCTGGTGCCCCTGGGCCTGGTGCTGGCAGTGGGAGCCGTGGCTGTGGGGGTGGCCAGAGCCCGGCACAGGAAGAACGTCGACCGAGTTTCAATCAGAAGCTACAGGACAGACATTAGCATGTCAGACTTCGAGAACTCCAGGGAATTTGGAGCCAATGACAACATGGGAGCCTCTTCGATCACTCAGGAGACATCCCTCGGAGGAAAAGAAGAGTTTGTTGCCACCACTGAGAGCACCACAGAGACCAAAGAACCCAAGAAGGCAAAAAGGTCATCCAAGGAGGAAGCCGAGATGGCCTACAAAGACTTCCTGCTCCAGTCCAGCACCGTGGCCGCCGAGGCCCAGGACGGCCCCCAGGAAGCCTAG
ORF Protein Sequence MLLFVLTCLLAVFPAISTKSPIFGPEEVNSVEGNSVSITCYYPPTSVNRHTRKYWCRQGARGGCITLISSEGYVSSKYAGRANLTNFPENGTFVVNIAQLSQDDSGRYKCGLGINSRGLSFDVSLEVSQGPGLLNDTKVYTVDLGRTVTINCPFKTENAQKRKSLYKQIGLYPVLVIDSSGYVNPNYTGRIRLDIQGTGQLLFSVVINQLRLSDAGQYLCQAGDDSNSNKKNADLQVLKPEPELVYEDLRGSVTFHCALGPEVANVAKFLCRQSSGENCDVVVNTLGKRAPAFEGRILLNPQDKDGSFSVVITGLRKEDAGRYLCGAHSDGQLQEGSPIQAWQLFVNEESTIPRSPTVVKGVAGGSVAVLCPYNRKESKSIKYWCLWEGAQNGRCPLLVDSEGWVKAQYEGRLSLLEEPGNGTFTVILNQLTSRDAGFYWCLTNGDTLWRTTVEIKIIEGEPNLKVPGNVTAVLGETLKVPCHFPCKFSSYEKYWCKWNNTGCQALPSQDEGPSKAFVNCDENSRLVSLTLNLVTRADEGWYWCGVKQGHFYGETAAVYVAVEERKAAGSRDVSLAKADAAPDEKVLDSGFREIENKAIQDPRLFAEEKAVADTRDQADGSRASVDSGSSEEQGGSSRALVSTLVPLGLVLAVGAVAVGVARARHRKNVDRVSIRSYRTDISMSDFENSREFGANDNMGASSITQETSLGGKEEFVATTESTTETKEPKKAKRSSKEEAEMAYKDFLLQSSTVAAEAQDGPQEA

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP1368-Ab Anti-PIGR monoclonal antibody
    Target Antigen GM-Tg-g-MP1368-Ag PIGR VLP (virus-like particle)
    ORF Viral Vector pGMLV001469 Human PIGR Lentivirus plasmid
    ORF Viral Vector vGMLV001469 Human PIGR Lentivirus particle


    Target information

    Target ID GM-MP1368
    Target Name PIGR
    Gene Group Identifier
    （Target Gene ID in Homo species)         		5284
    Gene ID 100055765 (Equus caballus), 101090323 (Felis catus), 18703 (Mus musculus), 25046 (Rattus norvegicus)
    281401 (Bos taurus), 474357 (Canis lupus familiaris), 5284 (Homo sapiens), 694638 (Macaca mulatta)
    Gene Symbols & Synonyms PIGR,Pigr,pIgA-R,RNPIGR2
    Target Alternative Names Hepatocellular carcinoma-associated protein TB6,PIGR,PIgR,Pigr,Poly-Ig receptor,Polymeric immunoglobulin receptor,RNPIGR2,pIgA-R
    Uniprot Accession O70570,P01833,P15083,P81265
    Additional SwissProt Accessions: O70570,P15083,P81265,P01833
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease Diabetic Nephropathy, Dent disease
    Disease from KEGG Intestinal immune network for IgA production
    Gene Ensembl ENSECAG00000016196, ENSMUSG00000026417, ENSBTAG00000019798, ENSCAFG00845001456, ENSG00000162896, ENSMMUG00000011220
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.